The Efficacy and Safety of Alprazolam Versus Other Benzodiazepines in the Treatment of Panic Disorder
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
We performed a meta-analysis of all single- or double-blind, randomized controlled trials comparing alprazolam to another benzodiazepine in the treatment of adult patients meeting the Diagnostic and Statistical Manual of Mental Disorders, Third or Fourth Edition, criteria for panic disorder or agoraphobia with panic attacks. Eight studies met inclusion criteria, describing a total of at least 631 randomized patients. In the pooled results, there were no significant differences in efficacy between alprazolam and the comparator benzodiazepines on any of the prespecified outcomes: improvement in mean panic attack frequency (between-arm weighted mean difference of 0.6 panic attacks per week; 95% confidence interval [CI], -0.3 to 1.6), improvement in Hamilton Anxiety Rating Scale score (weighted mean difference of 0.8 points; 95% CI, -0.5 to 2.1), and proportion of patients free of panic attacks at the final evaluation (pooled relative risk, 1.1; 95% CI, 0.9-1.4). Statistical heterogeneity on prespecified outcomes was not eliminated by stratification on baseline anxiety level. The available evidence fails to demonstrate alprazolam as superior to other benzodiazepines for the treatment of panic disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a 2011 meta-analysis of all single or double-blind, randomized controlled trials comparing alprazolam with other benzodiazepines in the treatment of panic disorder found no significant differences on any of the outcomes of clinical efficacy, including mean panic attack frequency, improvement in HAM-A score, and proportion of patients free of panic attacks at the final evaluation (Moylan et al., 2”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Moylan et al., 2011
Citations
Cites
Multicenter Collaborative Panic Disorder Severity Scale
Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1571 · Cited by 1,001
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 879
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Benzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 539
(2004) · PubMed · Cited by 296
Klerman, G. L. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.191 · Cited by 229
Pecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204
Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia
Furukawa, T. A., Watanabe, N., & Churchill, R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004364.pub2 · Cited by 195
Diazepam and Propranolol in Panic Disorder and Agoraphobia
Noyes, R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790140077009 · Cited by 184
Pivotal studies of clonazepam in panic disorder.
Davidson, J. R. T., & Moroz, G. (1998) · PubMed · Cited by 178
Research works printed but not linked: 1
- Meco, 1989, Etizolam: a new therapeutics possibility in the treatment of panic disorder., Adv Ther, 6, 196
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“While it has been suggested that alprazolam may be more effective, a metaanalysis found no evidence that it was superior to other benzodiazepines for the treatment of panic disorder [252].”
BackgroundA Review of Alprazolam Use, Misuse, and Withdrawal
Ait-Daoud, N., Hamby, A. S., Sharma, S., & Blevins, D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000350 · Cited by 195
“…other benzodiazepines in the treatment of panic disorder found no significant differences on any of the outcomes of clinical efficacy, including mean panic attack frequency, improvement in HAM-A score, and proportion of patients free of panic attacks at the final evaluation (Moylan et al., 2011).”
Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice
Dubovsky, S. L., & Marshall, D. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524400 · Cited by 171
Serotonin in anxiety and panic: Contributions of the elevated T-maze
Zangrossi, H., & Graeff, F. G. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.03.007 · Cited by 167
Sahn, J. J., Granger, B. A., & Martin, S. F. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00835a · Cited by 47
Metadata
- Authors
- Moylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M.
- Affiliations
- Mental Health Research Institute (AU)
- Western Health (AU)
- Government of Prince Edward Island (CA)
- University of Cape Town (ZA)
- Corresponding author
- Moylan, Steven
- Berk, Michael
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2011-10
- Volume
- 31
- Issue
- 5
- Pages
- 647-652
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1972150366
- Cited by
- 34
- References
- 55
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 2 · 2012: 2
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- alprazolam, benzodiazepines, panic disorder, treatment efficacy, drug safety, comparative drug effectiveness
- MeSH terms
- Agoraphobia, Alprazolam, Benzodiazepines, Humans, Psychiatric Status Rating Scales, Anti-Anxiety Agents, Randomized Controlled Trials as Topic, Panic Disorder, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Efficacy and Safety of Alprazolam Versus Other Benzodiazepines in the Treatment of Panic Disorder. https://app.cochat.ai/papers/10.1097/jcp.0b013e31822d0012
- The paper
- Moylan, S., Staples, J., Ward, S. A., Rogerson, J., Stein, D. J., & Berk, M. (2011). The Efficacy and Safety of Alprazolam Versus Other Benzodiazepines in the Treatment of Panic Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0b013e31822d0012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.